B6.Cg-Nr1i3tm1(NR1I3)Arte Cyp3a13tm1Nki Cyp3atm1109(CYP3A4,CYP3A7)Arte Cyp1a2tm2024.1(CYP1A2)Arte Cyp1a1tm2025.1(CYP1A1)Arte Cyp2dtm1836.1(CYP2D6_i2)Arte Nr1i2tm1(NR1I2)Arte Cyp2ctm1897.1(Alb-CYP2C9)Arte/Tac
Strain Detail
-
Strain Name
B6.Cg-Nr1i3tm1(NR1I3)Arte Cyp3a13tm1Nki Cyp3atm1109(CYP3A4,CYP3A7)Arte Cyp1a2tm2024.1(CYP1A2)Arte Cyp1a1tm2025.1(CYP1A1)Arte Cyp2dtm1836.1(CYP2D6_i2)Arte Nr1i2tm1(NR1I2)Arte Cyp2ctm1897.1(Alb-CYP2C9)Arte/Tac
-
Attributes
mutant strain,
targeted mutation
-
MGI ID
MGI:6405110
-
Synonyms
8HUM,
B6.Cg-Nr1i3tm1(NR1I3)Arte Cyp3a13tm1Ahs Cyp3atm1109(CYP3A4,CYP3A7)Arte Cyp1a2tm2024.1(CYP1A2)Arte Cyp1a1tm2025.1(CYP1A1)Arte Cyp2dtm1836.1(CYP2D6_i2)Arte Nr1i2tm1(NR1I2)Arte Cyp2ctm1897.1(Alb-CYP2C9)Arte/Tac
7 associated
mutations
Show All
-
Earliest
J:286122 Henderson CJ, et al., An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials. Drug Metab Dispos. 2019 Jun;47(6):601-615
-
All